Gang Xu - Publications

Membrane-bound transcription factor LRRC4 inhibits glioblastoma cell motility.

Journal: International journal of biological macromolecules

Published: March 04, 2023

HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness.

Journal: Current cancer drug targets

Published: September 17, 2022

C-Fos-activated circRPPH1 contributes to glioma stemness.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 12, 2022

Angiomotin-like 1 plays a tumor-promoting role in glioma by enhancing the activation of YAP1 signaling.

Journal: Environmental toxicology

Published: May 05, 2021

Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.

Journal: Oncotarget

Published: December 21, 2020

Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability.

Journal: Environmental toxicology

Published: September 15, 2020

Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis.

Journal: Environmental toxicology

Published: July 02, 2020

ATP-binding cassette transporter A1: A promising therapy target for prostate cancer.

Journal: Molecular and clinical oncology

Published: May 06, 2017

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells.

Journal: Journal of hematology & oncology

Published: July 14, 2016

Value of e-Flow combined with TI-RADS in qualitative diagnosis of thyroid nodules

Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery

Published: March 23, 2016

miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.

Journal: Oncotarget

Published: August 16, 2015

Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.

Journal: Oncology reports

Published: June 05, 2015